These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 32278570

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Use of Cardiotonic Drugs in Neonates.
    Dempsey E, Rabe H.
    Clin Perinatol; 2019 Jun; 46(2):273-290. PubMed ID: 31010560
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A Review of Inotropes and Inopressors for Effective Utilization in Patients With Acute Decompensated Heart Failure.
    Nandkeolyar S, Ryu R, Mohammad A, Cordero-Caban K, Abramov D, Tran H, Hauschild C, Stoletniy L, Hilliard A, Sakr A.
    J Cardiovasc Pharmacol; 2021 Sep 01; 78(3):336-345. PubMed ID: 34117179
    [Abstract] [Full Text] [Related]

  • 6. Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double-Blind Controlled Trial.
    Lannemyr L, Ricksten SE, Rundqvist B, Andersson B, Bartfay SE, Ljungman C, Dahlberg P, Bergh N, Hjalmarsson C, Gilljam T, Bollano E, Karason K.
    J Am Heart Assoc; 2018 Aug 21; 7(16):e008455. PubMed ID: 30369310
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Levosimendan as bridge to transplant in patients with advanced heart failure.
    Ponz de Antonio I, de Juan Bagudá JS, Rodríguez Chaverri A, García-Cosío Carmena MD, Arribas Ynsaurriaga F, Delgado Jiménez JF.
    Rev Esp Cardiol (Engl Ed); 2020 May 21; 73(5):422-424. PubMed ID: 32061565
    [No Abstract] [Full Text] [Related]

  • 15. Ambulatory levosimendan infusions. Effective and efficient in advanced heart failure?
    Dobarro D, Ribera-Solé A.
    Rev Esp Cardiol (Engl Ed); 2020 May 21; 73(5):345-347. PubMed ID: 32107145
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inotrope and vasopressor use in cardiogenic shock: what, when and why?
    Hu K, Mathew R.
    Curr Opin Crit Care; 2022 Aug 01; 28(4):419-425. PubMed ID: 35792520
    [Abstract] [Full Text] [Related]

  • 18. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality.
    Tarvasmäki T, Lassus J, Varpula M, Sionis A, Sund R, Køber L, Spinar J, Parissis J, Banaszewski M, Silva Cardoso J, Carubelli V, Di Somma S, Mebazaa A, Harjola VP, CardShock study investigators.
    Crit Care; 2016 Jul 04; 20(1):208. PubMed ID: 27374027
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis.
    Madeira M, Caetano F, Almeida I, Fernandes A, Reis L, Costa M, Gonçalves L.
    Rev Port Cardiol; 2017 Sep 04; 36(9):619-625. PubMed ID: 28826934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.